One-fifth of meningitis vaccine effective
One-fifth of the standard dose of a commonly used meningitis vaccine may be as effective as using the full dose, researchers in Norway said.
Researchers at the Norwegian Institute of Public Health and colleagues at Epicentre — the research arm of Doctors Without Borders/Medecins Sans Frontieres — and Mbarara University of Science and Technology in Uganda said the finding should allow scarce vaccine resources to be stretched further, especially during epidemics in Africa.
In 2004, a randomized clinical trial of 750 healthy volunteers ages 2-19 took place in Uganda. Their immune response, assessed by serum bactericidal activity, was measured for one-fifth and one-10th doses compared to a full dose.
Serum bactericidal activity response and safety/tolerability using one-fifth dose were comparable to a full dose for three serogroups — A, Y, W135, but not a fourth — C.
The study, published in the journal PLoS Neglected Tropical Diseases, said that in view of the current shortage of meningococcal vaccines for Africa, the use of one-fifth fractional doses should be considered as an alternative in mass vaccination campaigns.